Literature DB >> 21903541

Benefits of additional courses of systemic azithromycin in periodontal therapy.

Edgar Schmidt1, Niko Kaciroti, Walter Loesche.   

Abstract

The use of systemic antimicrobials such as doxycycline, metronidazole, and azithromycin in conjunction with debridement has achieved results superior to those produced by debridement alone. The purpose of the present study was to determine if previous results could be improved upon by administering repeated doses of azithromycin during the hygiene phase. One hundred patients with moderate to advanced periodontitis were treated with scaling and root planing plus three courses of azithromycin during the hygiene phase. All patients then were re-evaluated and periodontal surgery and/or extractions involving 96 teeth were performed in 32 patients. All patients then entered a maintenance program that lasted up to 192 weeks, with four-month recalls. Clinical parameters were recorded at baseline, at re-evaluation (week 6 after baseline), and at 96 and 192 weeks into maintenance. The results indicated that probing depths, bleeding upon probing, and suppuration were reduced significantly at re-evaluation. In addition, 14 teeth that displayed a Class III mobility at baseline improved to either Class I or Class II . There was no relapse during the maintenance phase. Multivariate analysis after 192 weeks indicated no change in the number of sites that bled upon probing, or had pockets that were 5.0-6.0 mm or ≥ 7 mm. Ninety-five percent of the sites that initially bled upon probing did not do so four years post-treatment. The results indicate that three courses of azithromicin in conjunction with root instrumentation during the hygiene phase led to long-lasting beneficial effects on all clinical parameters for at least 192 weeks.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21903541

Source DB:  PubMed          Journal:  Gen Dent        ISSN: 0363-6771


  2 in total

1.  Nonsurgical therapy of chronic periodontitis with adjunctive systemic azithromycin or amoxicillin/metronidazole.

Authors:  Holger F R Jentsch; Andreas Buchmann; Abel Friedrich; Sigrun Eick
Journal:  Clin Oral Investig       Date:  2015-12-19       Impact factor: 3.573

2.  Systemic azithromycin as an adjunct to scaling and root planing in patients with stage III/IV periodontitis: 12-month results of a randomized controlled clinical trial.

Authors:  Katja Povšič; Katarina Čuk; Suzana Milavec; Vanja Erčulj; Katja Seme; Rok Gašperšič
Journal:  Clin Oral Investig       Date:  2021-03-30       Impact factor: 3.573

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.